Marshall Wace’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,155
| Closed | -$15.1K | – | 2683 |
|
|
2025
Q1 | $15.1K | Sell |
19,155
-493,486
| -96% | -$390K | ﹤0.01% | 2423 |
|
|
2024
Q4 | $846K | Buy |
+512,641
| New | +$846K | ﹤0.01% | 1684 |
|
|
2024
Q3 | – | Sell |
-330,082
| Closed | -$1.08M | – | 2435 |
|
|
2024
Q2 | $1.08M | Sell |
330,082
-15,355
| -4% | -$50.4K | ﹤0.01% | 1497 |
|
|
2024
Q1 | $2.54M | Buy |
+345,437
| New | +$2.54M | ﹤0.01% | 1097 |
|
|
2022
Q1 | – | Sell |
-74,622
| Closed | -$4.37M | – | 2810 |
|
|
2021
Q4 | $4.37M | Sell |
74,622
-103,716
| -58% | -$6.07M | 0.01% | 1276 |
|
|
2021
Q3 | $10.6M | Buy |
178,338
+127,195
| +249% | +$7.54M | 0.04% | 465 |
|
|
2021
Q2 | $4.44M | Buy |
+51,143
| New | +$4.44M | 0.02% | 799 |
|
|
2021
Q1 | – | Sell |
-68,278
| Closed | -$6.21M | – | 2232 |
|
|
2020
Q4 | $6.21M | Buy |
+68,278
| New | +$6.21M | 0.03% | 460 |
|
|
2020
Q1 | – | Sell |
-16,273
| Closed | -$318K | – | 1733 |
|
|
2019
Q4 | $318K | Buy |
+16,273
| New | +$318K | ﹤0.01% | 1212 |
|